ABUS Q1 2026 Earnings Wider Loss Than Expected as Biotech Reports No Revenue SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Shares Decline 165 QURE Q1 2026 Earnings Narrowed Loss Beats Estimates as Gene Therapy Pipeline Steadies SQNS Q1 2026 Earnings Significant EPS Miss Amid Positive Stock Reaction ORCL Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Iovance Biotherapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Momentum